New Addiction Drug May be Blocked by FDA in the Midst of Opioid Epidemic

May 31, 2019 - /PressAdvantage/ - A drug that can rival Sublocade is ready to hit the market—but it may be blocked by the FDA for several years, despite the opioid crisis.

Sublocade is currently the only injectable form of buprenorphine, the drug that blocks cravings associated with addiction. Buprenorphine usually comes in tablets and dissolvable film, but the injectable form Sublocade is used for its longer lasting effects.

If the company that makes Sublocade gets its way, its rival drug will be blocked by the FDA and it will be the only long-acting buprenorphine on the market for five more years. This is because of a quirk in federal law that may prevent the competing drug called Brixadi from going on sale until 2024.

“It's ready for market now,” said Mike Derkacz, CEO of Braeburn, which makes Brixadi. “We are deemed safe and effective by FDA, but we are unable to make the product available to patients during this crisis.”

According to the National Institute on Drug Abuse, about 2.3 million people in the US were addicted to prescription opioids or illicit opiates like heroin. 47,000 people died of an overdose that same year. The Trump administration later declared opioid addiction a public health emergency, just a month before Sublocade hit the market. This made medication-assisted treatment a priority.

The makers of Brixadi were therefore shocked to hear that the FDA only gave their product tentative approval in December. Derkacz said it doesn’t make sense, since buprenorphine medications play such a key role in treating opioid addiction, especially now that there is an epidemic.

“There have been studies that show a reduction in mortality by 40% with buprenorphine,” he said. “That keeps people alive. That gives people a chance to get back to their lives and recover fully.”

More than 130 people in the US die of an opioid overdose every day. But a loophole in federal law might block Brixadi for a few more years.

“It's important to have multiple different treatment options for different patients, different circumstances,” said Carolyn Bogdon, a family nurse practitioner from Medical University of South Carolina in Charleston, S.C.

Buprenorphine is an opiate, but it does not give people the same high, and it instead blocks the cravings associated with addiction. This helps people who are going through medical detox while recovering from their addiction because they don’t feel the intense cravings caused by withdrawal.

Sublocade was first approved for sale in 2017. Like any new drug, it was granted three years of exclusive access to US markets. That time is up next year. But in December, the Food and Drug Administration told Braeburn that it might have to wait four more years because Sublocade was designated as an “orphan drug” which means it has seven years of exclusive access.

Normally, orphan drugs are medications that treat illnesses affecting fewer than 200,000 people a year. But because of the opioid epidemic, more people are dying of drug overdose. Click the link to see Bakersfield's top rehab placement programs.

Indivior created its first buprenorphine-based drug in the 1990s. At the time, treating addiction with other drugs was not mainstream. There were methadone clinics in some US cities, but they were heavily regulated by law. The company asked the FDA to give it orphan status because Indivior said it had little hope of earning back its investment in Subutex and needed extra time with no competition. Few drugs have received orphan status this way, but it made sense to the FDA at the time.

Subutex hit the market in 2002 soon after its orphan designation was granted. Since then, the company has made billions in revenue from sales of the drug, as well as its successors, Suboxone and Sublocade.

Indivior wrote: “Indivior stands by FDA's decision, which was supported by both the law and the facts at that time.”

Derkacz said that Braeburn has asked the FDA to revoke Sublocade’s orphan status, and an FDA spokeswoman said that the agency is actively considering that request in light of the epidemic.

Long-acting treatments for addiction have important benefits for certain patients. For starters, patients don’t have to remember to take their medication every day. They can avoid going to the drugstore because the medication is injected once a month.

“It provides a little bit more anonymity for patients that don't want to disclose that they have an opiate use disorder,” said Michelle Lofwall from the University of Kentucky. “Some patients have felt stigmatized when going to the pharmacy like they don't feel like they're necessarily treated all that well once they show their prescription.”

Lofwall is aware of the differences between Sublocade and Brixadi as she is one of the few health care providers who has used both medications. She believes that patients should have access to both options.

“From a public health perspective, and just as a provider physician trying to treat patients, they need to have all the options," she said. Being on the right drug "literally can save their life."

If someone in the family is struggling with opioid or alcohol addiction, it is important to seek help. A combination of medical detox and behavioral therapy can go a long way in the fight against drug abuse. But because every individual is affected by addiction differently, a comprehensive program tailored to their specific needs is necessary. Look for a nearby addiction treatment facility today and find out how drug treatment programs work.

###

For more information about Rehab Near Me: Bakersfield, contact the company here:

Rehab Near Me: Bakersfield
+1 256-500-8011

ReleaseID: 60028560

More News From Technology - Asia Logue

China criticizes Apple for app that tracks Hong Kong police

Oct 14, 2019

HONG KONG — Apple became the latest company targeted for Chinese pressure over protests in Hong Kong after the ruling Communist Party's main newspaper criticized the tech giant Wednesday for a smartphone app that allows activists to report police movements. HKmap.live, designed by an outside supplier and available on Apple Inc.'s online store, "facilitates illegal behavior," the People's Daily said in a commentary. "Is Apple guiding Hong Kong thugs?" the newspaper said. Beijing has pressed companies including Hong Kong's Cathay Pacific Airways to take the government's side against the protests, which are in their fourth month. Apple didn't immediately respond...

Indonesian province shuts schools due to forest fire haze

Oct 14, 2019

JAKARTA, Indonesia — Authorities shut most schools in parts of Indonesia's Sumatra island to protect children from a thick, noxious haze as deliberately set fires burned through peatland forests, officials said Wednesday. Indonesia's Disaster Mitigation Agency said more than 3,600 fires have been detected on Sumatra and Borneo islands by weather satellites, leading to very poor air quality in six provinces with a combined population of more than 23 million. Nearly every year, Indonesian forest fires spread health-damaging haze across the country and into neighboring Malaysia and Singapore. Authorities have deployed more than 9,000 people to fight the fires, which...

Indonesia to move capital from sinking Jakarta to Borneo

Oct 14, 2019

JAKARTA, Indonesia — Indonesia's president says the country's capital will move from overcrowded, sinking and polluted Jakarta to a site in sparsely populated East Kalimantan province on Borneo island, known for rainforests and orangutans. President Joko Widodo said Monday intense studies over the past three years had resulted in the choice of the location on the eastern side of Borneo island. The new capital city, which has not yet been named, will be in the middle of the vast archipelago nation and already has relatively complete infrastructure because it is near the cities of Balikpapan and Samarinda, Widodo said. He...

China lets currency sink to 11-year low after Trump threats

Oct 14, 2019

BEIJING — China allowed its yuan to sink to an 11-year low Monday after President Donald Trump sent jittery financial markets tumbling by announcing new tariff hikes and threatening to block American companies from doing business with this country. The escalation in the fight over trade and technology prompted warnings that chances for a settlement were disappearing. The yuan declined to 7.1468 to the dollar, a relatively modest change from Friday's low point of 7.0927 but its weakest rate since January 2008. The yuan has lost 6.5% from this year's high on Feb. 28. Chinese leaders have promised to avoid...

Indonesian walking 700 kilometers backward to save forests

Oct 14, 2019

BEKASI, Indonesia — An Indonesian man is walking more than 700 kilometers (430 miles) backward from his village in eastern Java to the country's capital to raise awareness about deforestation. Medi Bastoni began his arduous expedition on July 18 from his home on the slope of Mount Wilis, a dormant volcano in East Java province that has been affected by deforestation. The 43-year-old is expected to arrive in the capital, Jakarta, on Friday. He hopes to meet President Joko Widodo, and ask him to re-plant trees on Mount Wilis and elsewhere. "I'm doing this to raise people's awareness of deforestation,"...

Sign up now!

Advertisement